At VetDC, we pride ourselves in advancing the field of anti-cancer therapies for companion animals. And our work is beginning to get noticed! VetDC was recently featured in Animal Pharm, the leading online business intelligence service for the animal health sector, providing animal health professionals worldwide with news, analysis and insight.
VetDC cancer treatment set for US conditional approval decision in 2015
While Aratana Therapeutics and Kindred Biosciences have been grabbing headlines in recent years, there are other players generating advancements in the US animal health biotech space. Working with the Flint Animal Care Center at Colorado State University, VetDC is an animal pharmaceuticals company focused on bridging the gap between human and companion animal cancer treatments. Animal Pharm analyst Sian Lazell spoke to the firm about its history. READ MORE…
Read the whole article by Sian Lazell on the Animal Pharm site here.
Published February 25, 2015